Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Defining the Era of Shoulder Arthroscopy 2.0: A Perspective on Integrating Precision, Biology, and Smart Technology

Qin K., Liu C., Peng G., Song Y., Zhao L., Wang Y.

Laboratory Study on Shoulder, published in Arch Bone Jt Surg (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Arch Bone Jt Surg (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42246018
PMCID
PMC13231256
DOI
10.22038/abjs.2025.90032.4084

Abstract (original English)

Over the past four decades, shoulder arthroscopy has advanced from diagnostic exploration to sophisticated therapeutic procedures. However, current techniques remain limited in addressing complex pathologies. We propose the concept of the Era of Shoulder Arthroscopy 2.0 (ESA2.0)-defined by surgical precision, biological integration, and digital innovation. Technologies such as three-dimensional (3D) imaging, augmented reality, and robotics are being explored to enhance accuracy and reproducibility. Concurrently, biological strategies, including platelet-rich plasma, stem cells, and scaffold-based techniques, may improve healing. Smart systems, including AI-assisted diagnosis and wearable rehabilitation tools, support more personalized treatment and optimize outcomes. This paradigm may define a future standard in arthroscopic care, offering solutions to challenges previously deemed intractable.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research